Geneva, July 14 -- International Clinical Trials Registry received information related to the study (ISRCTN16822938) titled 'Study to investigate the temperature and dissolved oxygen levels in the uterine cavity of females with normal menstrual cycles' on July 3.
Study Type: Interventional
Study Design:
Multicenter feasibility non-randomised trial (Other, Safety)
Primary Sponsor: Verso Biosense Limited
Condition:
Reproductive health
Pregnancy and Childbirth
Intervention:
All participants would be enrolled into one group and will have the device implanted for 7 days only between days 14-21 of their menstrual cycle. The device will monitor uterine temperature and dissolved oxygen through the study week. Participants will have a fol...